battle of glp 1 delivery technologies New Drug System Could Reduce GLP-1 Shortage and Make It More Efficient Designing GLP-1 delivery: structural perspectives

Description

Both medications reduce appetite through different mechanismsWegovy via GLP-1-mediated satiety signals, and lisdexamfetamine through central stimulant effects

As these therapies reshape treatment approaches for obesity and potentially a range of other chronic conditions, theyre also prompting questions about access, long-term outcomes, and the future of innovation in chronic disease care

For the efficacy estimand, the LSM change in HbA1c from baseline at week 52 as the primary endpoint was 2.24%, 2.43%, and 2.58% with tirzepatide 5, 10, and 15 mg, respectively, versus 1.44% with insulin glargine

Prescription discount cards like Inside Rx save an average of 80% - These free programs work independently of insurance and can be combined with other savings strategies